VALCARE MEDICAL
Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product line includes solutions for the repair and replacement of the mitral valve as well as the repair of the tricuspid valve. Our breakthrough mitral valve treatment platform is based on a D-shaped ring which serves both as a docking station for Valcare’s unique replacement prosthesis, and as a highly-effective tool for mitral annulus repair
VALVE REPAIR
VALVE REPLACEMENT
NEWS & PRESS
Valcare touts 1st-in-human use of Amend annulplasty ring
Israeli heart valve device developer Valcare Medical today announced the 1st implantations of its Amend mitral valve repair annuloplasty ring, completing the 1st phase of its 1st-in-human multi-center clinical trial evaluating the device.
Valcare completes first phase of first-in-human Amend trial
Valcare developed the Amend mitral valve repair annuloplasty ring—a semi-rigid, a ’D’ shaped ring designed to emulate the current gold standard for patients who suffer from mitral valve regurgitation. In a series of cases, the ring was successfully trans apically delivered through a catheter-based delivery system, and was secured to the annulus by a series of novel integral anchors.